510 Understanding the roles of AKT1 loss and AKT2 activation during SCC progression
Cutaneous Squamous Cell Carcinoma (cSCC) represents about 20% of all non-melanoma skin cancers, with a dramatic increase in incidence in immunosuppressed patients. Since metastases of this disease are associated with a poor prognosis, there is interest in identifying new biomarkers of SCC metastasis as this could indicate new therapeutic targets. One potential candidate is the serine/threonine kinase AKT. AKT exists in two isoforms in the skin- AKT1 and AKT2- which perform different functions during skin homeostasis.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: R. Button, C. Harwood, R.F. O ’Shaughnessy Tags: Melanoma and Other Skin Cancers Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Dermatology | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma